Analysis of European mitochondrial haplogroups with Alzheimer disease risk

Joelle M. Van Der Walt, Yulia A. Dementieva, Eden R Martin, William K Scott, Kristin K. Nicodemus, Charles C. Kroner, Kathleen A. Welsh-Bohmer, Ann M. Saunders, Allen D. Roses, Gary W. Small, Donald E. Schmechel, P. Murali Doraiswamy, John Gilbert, Jonathan L. Haines, Jeffery M Vance, Margaret A Pericak-Vance

Research output: Contribution to journalArticle

199 Citations (Scopus)

Abstract

We examined the association of mtDNA variation with Alzheimer disease (AD) risk in Caucasians (989 cases and 328 controls) testing the effect of individual haplogroups and single nucleotide polymorphisms (SNPs). Logistic regression analyses were used to assess risk of haplogroups and SNPs with AD in both main effects and interaction models. Males classified as haplogroup U showed an increase in risk (OR=2.30; 95% CI, 1.03-5.11; P=0.04) of AD relative to the most common haplogroup H, while females demonstrated a significant decrease in risk with haplogroup U (OR=0.44; 95% CI, 0.24-0.80; P=0.007). Our results were independent of APOE genotype, demonstrating that the effect of mt variation is not confounded by APOE4 carrier status. We suggest that variations within haplogroup U may be involved in AD expression in combination with environmental exposures or nuclear proteins other than APOE.

Original languageEnglish
Pages (from-to)28-32
Number of pages5
JournalNeuroscience Letters
Volume365
Issue number1
DOIs
StatePublished - Jul 15 2004
Externally publishedYes

Fingerprint

Alzheimer Disease
Single Nucleotide Polymorphism
Environmental Exposure
Nuclear Proteins
Mitochondrial DNA
Logistic Models
Genotype
Regression Analysis

Keywords

  • Alzheimer disease
  • APOE
  • Mitochondrial haplogroups
  • mtDNA

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Analysis of European mitochondrial haplogroups with Alzheimer disease risk. / Van Der Walt, Joelle M.; Dementieva, Yulia A.; Martin, Eden R; Scott, William K; Nicodemus, Kristin K.; Kroner, Charles C.; Welsh-Bohmer, Kathleen A.; Saunders, Ann M.; Roses, Allen D.; Small, Gary W.; Schmechel, Donald E.; Murali Doraiswamy, P.; Gilbert, John; Haines, Jonathan L.; Vance, Jeffery M; Pericak-Vance, Margaret A.

In: Neuroscience Letters, Vol. 365, No. 1, 15.07.2004, p. 28-32.

Research output: Contribution to journalArticle

Van Der Walt, JM, Dementieva, YA, Martin, ER, Scott, WK, Nicodemus, KK, Kroner, CC, Welsh-Bohmer, KA, Saunders, AM, Roses, AD, Small, GW, Schmechel, DE, Murali Doraiswamy, P, Gilbert, J, Haines, JL, Vance, JM & Pericak-Vance, MA 2004, 'Analysis of European mitochondrial haplogroups with Alzheimer disease risk', Neuroscience Letters, vol. 365, no. 1, pp. 28-32. https://doi.org/10.1016/j.neulet.2004.04.051
Van Der Walt, Joelle M. ; Dementieva, Yulia A. ; Martin, Eden R ; Scott, William K ; Nicodemus, Kristin K. ; Kroner, Charles C. ; Welsh-Bohmer, Kathleen A. ; Saunders, Ann M. ; Roses, Allen D. ; Small, Gary W. ; Schmechel, Donald E. ; Murali Doraiswamy, P. ; Gilbert, John ; Haines, Jonathan L. ; Vance, Jeffery M ; Pericak-Vance, Margaret A. / Analysis of European mitochondrial haplogroups with Alzheimer disease risk. In: Neuroscience Letters. 2004 ; Vol. 365, No. 1. pp. 28-32.
@article{3d75f3ee20ce45c48966abf2077eeb15,
title = "Analysis of European mitochondrial haplogroups with Alzheimer disease risk",
abstract = "We examined the association of mtDNA variation with Alzheimer disease (AD) risk in Caucasians (989 cases and 328 controls) testing the effect of individual haplogroups and single nucleotide polymorphisms (SNPs). Logistic regression analyses were used to assess risk of haplogroups and SNPs with AD in both main effects and interaction models. Males classified as haplogroup U showed an increase in risk (OR=2.30; 95{\%} CI, 1.03-5.11; P=0.04) of AD relative to the most common haplogroup H, while females demonstrated a significant decrease in risk with haplogroup U (OR=0.44; 95{\%} CI, 0.24-0.80; P=0.007). Our results were independent of APOE genotype, demonstrating that the effect of mt variation is not confounded by APOE4 carrier status. We suggest that variations within haplogroup U may be involved in AD expression in combination with environmental exposures or nuclear proteins other than APOE.",
keywords = "Alzheimer disease, APOE, Mitochondrial haplogroups, mtDNA",
author = "{Van Der Walt}, {Joelle M.} and Dementieva, {Yulia A.} and Martin, {Eden R} and Scott, {William K} and Nicodemus, {Kristin K.} and Kroner, {Charles C.} and Welsh-Bohmer, {Kathleen A.} and Saunders, {Ann M.} and Roses, {Allen D.} and Small, {Gary W.} and Schmechel, {Donald E.} and {Murali Doraiswamy}, P. and John Gilbert and Haines, {Jonathan L.} and Vance, {Jeffery M} and Pericak-Vance, {Margaret A}",
year = "2004",
month = "7",
day = "15",
doi = "10.1016/j.neulet.2004.04.051",
language = "English",
volume = "365",
pages = "28--32",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Analysis of European mitochondrial haplogroups with Alzheimer disease risk

AU - Van Der Walt, Joelle M.

AU - Dementieva, Yulia A.

AU - Martin, Eden R

AU - Scott, William K

AU - Nicodemus, Kristin K.

AU - Kroner, Charles C.

AU - Welsh-Bohmer, Kathleen A.

AU - Saunders, Ann M.

AU - Roses, Allen D.

AU - Small, Gary W.

AU - Schmechel, Donald E.

AU - Murali Doraiswamy, P.

AU - Gilbert, John

AU - Haines, Jonathan L.

AU - Vance, Jeffery M

AU - Pericak-Vance, Margaret A

PY - 2004/7/15

Y1 - 2004/7/15

N2 - We examined the association of mtDNA variation with Alzheimer disease (AD) risk in Caucasians (989 cases and 328 controls) testing the effect of individual haplogroups and single nucleotide polymorphisms (SNPs). Logistic regression analyses were used to assess risk of haplogroups and SNPs with AD in both main effects and interaction models. Males classified as haplogroup U showed an increase in risk (OR=2.30; 95% CI, 1.03-5.11; P=0.04) of AD relative to the most common haplogroup H, while females demonstrated a significant decrease in risk with haplogroup U (OR=0.44; 95% CI, 0.24-0.80; P=0.007). Our results were independent of APOE genotype, demonstrating that the effect of mt variation is not confounded by APOE4 carrier status. We suggest that variations within haplogroup U may be involved in AD expression in combination with environmental exposures or nuclear proteins other than APOE.

AB - We examined the association of mtDNA variation with Alzheimer disease (AD) risk in Caucasians (989 cases and 328 controls) testing the effect of individual haplogroups and single nucleotide polymorphisms (SNPs). Logistic regression analyses were used to assess risk of haplogroups and SNPs with AD in both main effects and interaction models. Males classified as haplogroup U showed an increase in risk (OR=2.30; 95% CI, 1.03-5.11; P=0.04) of AD relative to the most common haplogroup H, while females demonstrated a significant decrease in risk with haplogroup U (OR=0.44; 95% CI, 0.24-0.80; P=0.007). Our results were independent of APOE genotype, demonstrating that the effect of mt variation is not confounded by APOE4 carrier status. We suggest that variations within haplogroup U may be involved in AD expression in combination with environmental exposures or nuclear proteins other than APOE.

KW - Alzheimer disease

KW - APOE

KW - Mitochondrial haplogroups

KW - mtDNA

UR - http://www.scopus.com/inward/record.url?scp=3242707016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242707016&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2004.04.051

DO - 10.1016/j.neulet.2004.04.051

M3 - Article

C2 - 15234467

AN - SCOPUS:3242707016

VL - 365

SP - 28

EP - 32

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1

ER -